Literature DB >> 8902772

The catastrophic antiphospholipid syndrome 1996: acute multi-organ failure associated with antiphospholipid antibodies: a review of 31 patients.

R A Asherson1, J C Piette.   

Abstract

Thirty one patients with antiphospholipid antibodies who developed multi-organ failure ("Catastrophic Antiphospholipid Syndrome") are reviewed. Thirteen suffered from a 'Primary' antiphospholipid syndrome, 13 from defined SLE, 4 from 'lupus-like' disease and one from rheumatoid arthritis. In more than one third precipitating factors were evident (e.g. infections, major/minor surgical procedures, oral contraceptives). Death occurred in 60% of patients from a variety of causes (myocardial failure, ARDS, CNS causes or, often a combination). Disseminated Intravascular Coagulation was present in 8 of 31 patients. Plasmapheresis appeared to be useful in several who had not responded to conventional therapy (e.g. IV heparin, steroids, immunosuppression).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8902772     DOI: 10.1177/096120339600500516

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

Review 1.  Treatment of the antiphospholipid antibody syndrome: progress in the last five years?

Authors:  M Petri
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

Review 2.  Diagnosis and management of patients with the antiphospholipid syndrome.

Authors:  B M Alving
Journal:  J Thromb Thrombolysis       Date:  2001-09       Impact factor: 2.300

3.  Multiple steno-obstructive vascular lesions and femoral superficial artery dissection in a young Caucasian male with antiphospholipid syndrome.

Authors:  Rosario Cianci; Antonietta Gigante; Biagio Barbano; Alvaro Zaccaria; Lelio Polidori; Francesca Borghesi; Ludovica Gasperini; Domenico Di Donato; Antonio Amoroso
Journal:  BMJ Case Rep       Date:  2009-05-12

4.  Pediatric APS: State of the Art.

Authors:  Arzu Soybilgic; Tadej Avcin
Journal:  Curr Rheumatol Rep       Date:  2020-03-03       Impact factor: 4.592

Review 5.  Antiphospholipid syndrome; its implication in cardiovascular diseases: a review.

Authors:  Ioanna Koniari; Stavros N Siminelakis; Nikolaos G Baikoussis; Georgios Papadopoulos; John Goudevenos; Efstratios Apostolakis
Journal:  J Cardiothorac Surg       Date:  2010-11-03       Impact factor: 1.637

6.  Lethal End of Spectrum of Clots-Thrombotic Storm.

Authors:  Muhammad Asim Rana; Ahmed F Mady; Abdullah Ali Lashari; Rehab Eltreafi; Nicola Fischer-Orr; Kamal Naser
Journal:  Case Rep Crit Care       Date:  2018-05-27

Review 7.  Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management.

Authors:  Silvia Rosina; Cecilia Beatrice Chighizola; Angelo Ravelli; Rolando Cimaz
Journal:  Curr Rheumatol Rep       Date:  2021-01-28       Impact factor: 4.592

8.  A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome.

Authors:  Gerd Gladigau; Philipp Haselmayer; Inge Scharrer; Markus Munder; Nadine Prinz; Karl Lackner; Hansjörg Schild; Pamela Stein; Markus P Radsak
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

9.  Unveiling Uncommon Manifestations in a Pediatric Patient With Systemic Lupus Erythematosus: A Case Report.

Authors:  Raksha Ranjan; Sonalika Mehta; Kanchan N Saxena
Journal:  Cureus       Date:  2021-12-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.